Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Orthopedics ; 44(2): e223-e228, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33373461

RESUMEN

On clinical observation, it was found that the bone mineral density (BMD) of the femoral head and proximal femur was not consistent in some patients with femoral neck fracture after surgery. The current study was performed to explore whether this phenomenon was associated with femoral head necrosis after surgery for femoral neck fracture. Bone mineral density inconsistency is when the difference of the sum of pixel values on both sides of the fracture line has exceeded 30%. Statistical analysis was performed on the clinical characteristics of 271 patients who had received the operation for femoral neck fracture. Chi-square test, Spearman rank correlation, independent sample t test, Kaplan-Meier method, and log-rank test, as well as univariate Cox regression and multivariate Cox regression, were used to analyze the potential relationship among related factors. It was revealed that the incidence of inconsistency in BMD between the femoral head and proximal femur was significantly increased in patients with femoral head necrosis after surgery for femoral neck fracture, and that the consistency was considerably high between BMD inconsistency and femoral head necrosis. The inconsistent BMD occurred 11.1 months earlier than the necrosis of the femoral head. Cox multivariate regression analysis indicated that the inconsistency in BMD between the femoral head and proximal femur after surgery for femoral neck fracture was an independent prognostic factor affecting femoral head necrosis. The inconsistent changes in BMD between the femoral head and proximal femur after surgery for femoral neck fracture indicate a great possibility of femoral head necrosis. [Orthopedics. 2021;44(2):e223-e228.].


Asunto(s)
Densidad Ósea , Fracturas del Cuello Femoral/cirugía , Necrosis de la Cabeza Femoral/fisiopatología , Adulto , Anciano , Necrosis de la Cabeza Femoral/diagnóstico , Humanos , Masculino , Persona de Mediana Edad
2.
Oncotarget ; 8(31): 50896-50903, 2017 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-28881613

RESUMEN

The purpose of the present study was to investigate the prognostic value of Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5) in hepatocellular carcinoma (HCC) and its role in promoting HCC metastasis. The expression level of LGR5 in liver tumor tissues and adjacent non-tumor tissues were detected adopting immunohistochemistry (IHC), real-time PCR (RT-PCR) and western blot assays. Chi-square test was used to evaluate the correlation between LGR5 expression and clinicopathological characteristics. In addition, we assessed the relationship between LGR5 and two epithelial-mesenchymal transition (EMT) markers (E-cadherin and N-cadherin) in HCC tissues and cell lines. Our results showed that the expression of LGR5 was significantly higher in liver tumor tissues than in adjacent non-tumor tissues. Moreover, up-regulated LGR5 was associated with larger tumor diameter (>5cm, P=0.001), higher TNM stage (P=0.021), increased recurrence (P=0.023) and growing metastasis (P=0.030). Besides, we found that the expression level of LGR5 was correlated with E-cadherin and N-cadherin. In conclusion, up-regulated LGR5 in HCC patients is associated with malignant clinicopathological characteristics. LGR5 may promote HCC metastasis through inducting EMT process, and thus can be regarded as a candidate biomarker for prognosis and as a target in therapy.

3.
Oncotarget ; 8(1): 1132-1140, 2017 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-27902472

RESUMEN

Raf kinase inhibitor protein (RKIP) has been shown to be a suppressor of the mitogen-activated protein kinase pathway and is reported to be involved in human malignancy. However, the molecular mechanism of hepatitis B virus (HBV) in regulating RKIP expression is not yet clarified. In this study, we compared RKIP expression in 107 pairs of matched liver cancer and adjacent non-cancerous liver tissues. Among seven HBV-encoded proteins, we found HBV X (HBX) protein could significantly inhibit the expression level of RKIP, indicating that HBV could suppress RKIP expression through regulating HBX. To further elucidate the mechanism, analyses on transcriptional regulation and promoter methylation inhibition were conducted in Huh7 cells. Our results showed that HBX can interact with AP1 protein to inhibit the RKIP transcription. Moreover, we observed that the promoter methylation level of RKIP could be enhanced by HBV. In conclusion, our study revealed that RKIP could act as a molecular marker for HBV-infected liver cancer, but had no tumor-suppressing effect.


Asunto(s)
Carcinoma Hepatocelular/etiología , Regulación Neoplásica de la Expresión Génica , Virus de la Hepatitis B/fisiología , Neoplasias Hepáticas/etiología , Proteínas de Unión a Fosfatidiletanolamina/genética , Línea Celular Tumoral , Metilación de ADN , Hepatitis B/complicaciones , Hepatitis B/virología , Humanos , Regiones Promotoras Genéticas , Unión Proteica , ARN Mensajero/genética , ARN Mensajero/metabolismo , Transactivadores/metabolismo , Factor de Transcripción AP-1/metabolismo , Activación Transcripcional , Proteínas Reguladoras y Accesorias Virales
4.
PLoS One ; 10(10): e0140329, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26451736

RESUMEN

BACKGROUND: Epigenetic studies demonstrate that an association may exist between methylation of the retinoic acid receptor beta2 (RARß2) gene promoter and breast cancer onset risk, tumor stage, and histological grade, however the results of these studies are not consistent. Hence, we performed this meta-analysis to ascertain a more comprehensive and accurate association. MATERIALS AND METHODS: Relevant studies were retrieved from the PubMed, Embase and Chinese National Knowledge Infrastructure databases up to February 28, 2015. After two independent reviewers screened the studies and extracted the necessary data, meta-analysis was performed using Review Manager 5.2 software. RESULTS: Nineteen eligible articles, including 20 studies, were included in our analysis. Compared to non-cancerous controls, the frequency of RARß2 methylation was 7.27 times higher in patients with breast cancer (odds ratio (OR) = 7.27, 95% confidence interval (CI) = 3.01-17.52). Compared to late-stage RARß2 methylated patients, the pooled OR of early-stage ones was 0.81 (OR = 0.81, 95% CI = 0.55-1.17). The OR of low-grade RARß2 methylated patients was 0.96 (OR = 0.96, 95% CI = 0.74-1.25) compared to high-grade RARß2 methylated patients. CONCLUSION: RARß2 methylation is significantly increased in breast cancer samples when compared to non-cancerous controls. RARß2 could serve as a potential epigenetic marker for breast cancer detection and management.


Asunto(s)
Neoplasias de la Mama/genética , Metilación de ADN , Predisposición Genética a la Enfermedad/genética , Regiones Promotoras Genéticas/genética , Receptores de Ácido Retinoico/genética , Neoplasias de la Mama/patología , Humanos
5.
Med Sci Monit ; 21: 3048-53, 2015 Oct 09.
Artículo en Inglés | MEDLINE | ID: mdl-26451982

RESUMEN

BACKGROUND: Many studies have reported that the p53 codon 72 polymorphism is associated with acute myeloid leukemia (AML) susceptibility; however, the conclusions are inconsistent. Therefore, we performed this meta-analysis to obtain a more precise result. MATERIAL AND METHODS: We searched PubMed to identify relevant studies, and 6 published case-control studies were retrieved, including 924 AML patients and 3832 controls. Odds ratio (OR) with corresponding 95% confidence interval (95%CI) was applied to assess the association between p53 codon 72 polymorphism and AML susceptibility. The meta-analysis was performed with Comprehensive Meta-Analysis software, version 2.2. RESULTS: Overall, no significant association between p53 codon 72 polymorphism and AML susceptibility was found in this meta-analysis (Pro vs. Arg: OR=0.94, 95%CI=0.81-1.10; Pro/Pro vs. Arg/Arg: OR=0.93, 95%CI=0.71-1.22; Arg/Pro vs. Arg/Arg: OR=0.79, 95%CI=0.55-1.13; (Pro/Pro + Arg/Pro) vs. Arg/Arg: OR=0.84, 95%CI=0.62-1.13; Pro/Pro vs. (Arg/Arg + Arg/Pro): OR=1.06, 95%CI=0.83-1.35). Similar results were also found in stratified analysis according to ethnicity and source of controls. CONCLUSIONS: Our meta-analysis demonstrates that p53 codon 72 polymorphism may not be a risk factor for AML, which should be verified in future studies.


Asunto(s)
Predisposición Genética a la Enfermedad , Leucemia Mieloide Aguda/genética , Polimorfismo Genético , Proteína p53 Supresora de Tumor/genética , Estudios de Casos y Controles , Codón , Genotipo , Humanos , Oportunidad Relativa , Reproducibilidad de los Resultados , Factores de Riesgo
6.
Asian Pac J Cancer Prev ; 14(11): 6433-8, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24377546

RESUMEN

In hepatocellular cancer (HCC), lack of response to chemotherapy and radiation treatment can be caused by a loss of epigenetic modifications of cancer cells. Methionine adenosyltransferase 1A is inactivated in HCC and may be stimulated by an epigenetic change involving promoter hypermethylation. Therefore, drugs releasing epigenetic repression have been proposed to reverse this process. We studied the effect of the demethylating reagent 5-aza-2<-deoxycitidine (5-Aza-CdR) on MAT1A gene expression, DNA methylation and S-adenosylmethionine (SAMe) production in the HCC cell line Huh7. We found that MAT1A mRNA and protein expression were activated in Huh7 cells with the treatment of 5-Aza-CdR; the status of promoter hypermethylation was reversed. At the same time, MAT2A mRNA and protein expression was significantly reduced in Huh7 cells treated with 5-Aza-CdR, while SAMe production was significantly induced. However, 5-Aza-CdR showed no effects on MAT2A methylation. Furthermore, 5-Aza-CdR inhibited the growth of Huh7 cells and induced apoptosis and through down-regulation of Bcl-2, up-regulation of Bax and caspase-3. Our observations suggest that 5-Aza- CdR exerts its anti-tumor effects in Huh7 cells through an epigenetic change involving increased expression of the methionine adenosyltransferase 1A gene and induction of S-adenosylmethionine production.


Asunto(s)
Apoptosis/efectos de los fármacos , Azacitidina/análogos & derivados , Carcinoma Hepatocelular/tratamiento farmacológico , Neoplasias Hepáticas/tratamiento farmacológico , Metionina Adenosiltransferasa/biosíntesis , S-Adenosilmetionina/biosíntesis , Azacitidina/farmacología , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patología , Caspasa 3/genética , Línea Celular Tumoral , Metilación de ADN/efectos de los fármacos , Decitabina , Regulación hacia Abajo/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patología , Metionina Adenosiltransferasa/genética , Proteínas Proto-Oncogénicas c-bcl-2/genética , S-Adenosilmetionina/genética , Regulación hacia Arriba/efectos de los fármacos , Proteína X Asociada a bcl-2/genética
7.
Microbiology ; (12)2008.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-685948

RESUMEN

Carbon-nitrogen lyases (E.C.4.3) are a group of enzymes that release ammonia, amidine or amino group etc, and also show ability to form double bond or ring structure. Specifically, enzymes forming amino group are called amine-lyases (E.C.4.3.3), which are critical in the industrial production of many medicine intermediates. In this review is a summary of four major amine-lyases in terms of their source, enzymatic characteristics and their applications in preparation of pharmaceutical intermediates.

8.
Microbiology ; (12)2008.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-686110

RESUMEN

Bioprocess equipment is of great importance in application of modern industrial biotechnology.With the rapid development of industrial biotechnology,demands for talents capable of understanding the theory,design and manipulation of modern bioprocess equipment increased.The experiences in aspects such as the building of teachers' contingent,construction of teaching materials,innovation of teaching method from the top-quality course construction of Bioprocess Equipment was discussed in this paper.

9.
Microbiology ; (12)2008.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-686385

RESUMEN

Tautomycin is one of well-known specific protein phosphatase inhibitors and exhibiting potent antifungal ability, especially to Sclerotinia sclerotiolum. This article reviews the recent research progress of tautomycin, focusing on its inhibition region and biosynthesis.

10.
Microbiology ; (12)1992.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-683974

RESUMEN

Phaffia rhodozyma is a good strain for astaxanthin production. An over-producing mutant YB-20-29 was obtained by means of Cs137-?ray and N-methy1-N'-nitro-N-nitrosoguanidin (NTG) treatment. The biomass for this strain by shake culture was 36.32 g/L, the pigment content was 1216.0 ?g/g, an increase of 308% compare to o-riginal strain. The astaxanthin content in broth was 30.9?g /mL. It was a potential strain for astaxanthin over-production.

11.
Microbiology ; (12)1992.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-684658

RESUMEN

Solid state fermentation involves the growth of microorganisms on moist solid substrates in the absence of free flowing water. It has gained considerable attention of late years due to its several advantages over submerged fermentation. This paper mainly introduces the characteristics and mathematical models of solid state fermentation and summarizes the development situation of various bioreactors, the design standards and applications.

12.
Microbiology ; (12)1992.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-684790

RESUMEN

A Comprehensive review was present on the sources, enzyme stru cture, enzyme reaction mechanism and the application of the nitrilase.

13.
Microbiology ; (12)1992.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-685749

RESUMEN

The astaxanthin synthesized by Phaffia rhodozyma is a commercially valuable carotenoid. Related advances in the biosynthetic pathway of astaxanthin and the regulatory mechanisms of biosynthesis in Phaffia rhodozyma in recent years were reviewed.The innovating research aspects in related fields in China were also proposed.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA